share_log

平安健康2024年中期业绩:公司首次盈利上岸,战略业务同比增长19.7%

Ping An Health's mid-term performance in 2024: the company's first profitable year, with a 19.7% year-on-year growth in global strategic business.

Gelonghui Finance ·  Aug 20 04:43

On August 20th, Ping An Healthcare and Technology Co., Ltd. (stock abbreviation "Ping An Good Doctor", 1833.HK, hereinafter referred to as "Ping An Health" or "the Company") released its mid-term performance report for 2024.

During the reporting period, the company's revenue was 2.09 billion yuan, achieving a profit of over 60 million for the first time, and the net profit after adjustment was nearly 90 million. Among them, the strategic business revenue increased by 19.7% year-on-year, achieving steady growth. The service income of insurance and financial clients (F-end) was 1.12 billion yuan, a year-on-year increase of 3.4%. The employee health management service income of the enterprise (B-end) reached 0.71 billion yuan, a year-on-year increase of 58.8%.

As the flagship of Ping An Group's medical and retirement ecosystem, Ping An Health adheres to the management-oriented medical strategy, continuously deepens the coordination between medical care and insurance, upgrades its layered service capabilities, achieves double growth in F-end income and users, and has about 14.8 million paid users in the first half of the year, a year-on-year increase of 7%. At the same time, enterprise health management is another important strategic layout for the deepening of the company's Strategy 2.0 and is also the core driving force for the company's long-term growth. With the continuous improvement of the penetration rate of Ping An Group's enterprise customers and the continuous growth of self-developed enterprise customers, the development of B-end business is strong, and the number of enterprise clients served has also increased rapidly. As of the end of the reporting period, the cumulative number of enterprise customers served has reached 1,748, a year-on-year increase of 46%, firmly occupying the market leading position.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment